0001209191-22-002749.txt : 20220110 0001209191-22-002749.hdr.sgml : 20220110 20220110182359 ACCESSION NUMBER: 0001209191-22-002749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220110 DATE AS OF CHANGE: 20220110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stankovic Srdjan R. CENTRAL INDEX KEY: 0001432545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 22522323 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-06 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001432545 Stankovic Srdjan R. C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 President Common Stock 2022-01-06 4 M 0 5444 A 46956 D Common Stock 2022-01-06 4 S 0 1937 23.05 D 45019 D Restricted Stock Units 2022-01-06 4 M 0 5444 0.00 D Common Stock 5444 10889 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The restricted stock units vest in four equal annual installments beginning January 6, 2021. /s/ Austin D. Kim, Attorney-in-Fact 2022-01-10